Meltacib Trademark Details

Meltacib was registered on Tuesday, October 9, 2007 and is currently owned by Sanofi under the registration number 3306327 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 9 years ago on Friday, May 16, 2014, according to the United State Patent & Trademark Office
Word Mark Meltacib
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi

Previous Owners

Sanofi-Aventis of Allen, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis
Serial Number 77106102
Registration Number 3306327
Status Date Friday, May 16, 2014
Filing Date Friday, May 16, 2014
Registration Date Tuesday, October 9, 2007
Attorney Midge M. Hyman
Domestic Representative Midge M. Hyman, Arthur J. Greenbaum, William M. Borchard, Lynn S. Fruchter, Baila H. Celedonia, Morton D. Goldberg, Mary L. Kevlin, Jeffrey H. Epstein, Mark Montague, Robert W. Clarida, Dorothy R. Whitney, Deborah K. Squiers, Albert Robin, Arlana S.

Correspondent

MIDGE M. HYMAN
COWAN, LIEBOWITZ & LATMAN, P.C.
1133 AVENUE OF THE AMERICAS
NEW YORK, NY 10036-6710

Case File Statements

Goods & Services Pharmaceutical Preparations and Substances for the Treatment of Cancer

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, May 16, 2014
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.